Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent

Acta Pharmaceutica Sinica. B
Zongru JiangQingsong Liu

Abstract

Angiogenesis is an essential process in tumor growth, invasion and metastasis. VEGF receptor 2 (VEGFR2) inhibitors targeting tumor angiogenic pathway have been widely used in the clinical cancer treatment. However, most of currently used VEGFR2 kinase inhibitors are multi-target inhibitors which might result in target-associated side effects and therefore limited clinical toleration. Highly selective VEGFR inhibitors are still highly demanded from both basic research and clinical application point of view. Here we report the discovery and characterization of a novel VEGFR2 inhibitor (CHMFL-VEGFR2-002), which exhibited high selectivity among structurally closed kinases including PDGFRs, FGFRs, CSF1R, etc. CHMFL-VEGFR2-002 displayed potent inhibitory activity against VEGFR2 kinase in the biochemical assay (IC50 = 66 nmol/L) and VEGFR2 autophosphorylation in cells (EC50s ∼100 nmol/L) as well as potent anti-proliferation effect against VEGFR2 transformed BaF3 cells (GI50 = 150 nmol/L). In addition, CHMFL-VEGFR2-002 also displayed good anti-angiogenesis efficacy in vitro and exhibited good in vivo PK (pharmacokinetics) profile with bioavailability over 49% and anti-angiogenesis efficacy in both zebrafish and mouse models without app...Continue Reading

References

Jul 1, 1995·Developmental Dynamics : an Official Publication of the American Association of Anatomists·C B KimmelT F Schilling
Feb 26, 2000·Carcinogenesis·R S Kerbel
Sep 23, 2000·Nature·P Carmeliet, R K Jain
Oct 3, 2002·Nature Reviews. Cancer·Robert Kerbel, Judah Folkman
Jun 5, 2003·Nature Reviews. Cancer·Gabriele Bergers, Laura E Benjamin
May 12, 2004·Nature Reviews. Drug Discovery·Napoleone FerraraWilliam Novotny
Dec 9, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel J Hicklin, Lee M Ellis
Nov 23, 2005·Oncology·Peter Carmeliet
Apr 25, 2006·Nature Reviews. Molecular Cell Biology·Anna-Karin OlssonLena Claesson-Welsh
Nov 8, 2006·Annals of Internal Medicine·Jayesh DesaiErik K Alexander
Jan 5, 2007·Journal of the National Cancer Institute·Brian I RiniRonald M Bukowski
Mar 9, 2007·Blood Cells, Molecules & Diseases·Zaher K OtrockAli I Shamseddine
Apr 13, 2007·The New England Journal of Medicine·Pascal WolterPatrick Schöffski
Jun 3, 2009·Clinical and Experimental Dermatology·D J FifeK G Linden
Oct 22, 2009·British Journal of Cancer·R KumarA G King
Dec 17, 2009·Angiogenesis·Kristy J Gotink, Henk M W Verheul
Feb 11, 2010·Thyroid : Official Journal of the American Thyroid Association·Aljosja RogiersPatrick Schöffski
Sep 19, 2012·Proceedings of the National Academy of Sciences of the United States of America·Michele McTigueRobert S Kania
Jun 5, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V Di MarcoC Verslype
Sep 7, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-C SoriaJ Tabernero
Nov 26, 2014·Expert Opinion on Pharmacotherapy·Ruixuan Geng, Jin Li
Feb 24, 2015·Biochemical and Biophysical Research Communications·Yao YuYi Shao
Mar 17, 2018·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ana M MolinaTim Eisen

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
Assay
transgenic
xenograft
NMR
column chromatography
PCR

Software Mentioned

GraphPad
Prism
ImageXpress
ImageJ
Schrödinger Suite

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.